EU AI Act · MDR · IEC 62304 · ISO 14971
When your AI has to pass – not just perform.
Risk-based evaluation of AI/ML models with focus on data quality, validation, explainability and regulatory compliance – from development to approval.
Many AI models look ready to ship — yet reveal gaps under regulatory scrutiny.
Unclear representativeness, labeling inconsistencies and undetected bias compromise model reliability.
Insufficient test-train separation, missing external validation and overfitting risks remain undetected.
Missing version control, unclear change management and no robustness strategy create long-term risk.
Left undetected, these gaps cause approval delays, costly rework and avoidable regulatory risk.
I work with organizations deploying AI in regulated medical environments – who need external expertise for technical assurance.
Your data scientists build strong models – but the regulatory know-how for AI is missing. It works; is it also validated and documented to MDR standards?
SaMD startups, digital health, AI diagnostics
You've mastered MDR – but AI models raise new questions. How do you validate a model that changes with every update? How do you document training data per IEC 62304?
Endoscopy, imaging, monitoring, implants
Your investment committee asks: "Is the AI market-ready AND approvable?" I deliver the technical due diligence for sound decisions.
Digital health VCs, life sciences funds
Structured, independent assessments – the external perspective internal teams rarely have on their own model.
Rapid assessment of your AI/ML model covering top risks, critical gaps and immediate recommendations.
Comprehensive evaluation across all critical domains with detailed scoring and structured findings.
Independent technical assessment for investors: Is the AI model technically sound, regulatory-viable and scalable?
Launch phase 2026
For the first pilot projects, I work closely and collaboratively with selected clients – at reduced rates. You receive a particularly intensive, hands-on engagement; I build referenceable case studies. A fair exchange for both sides.
Systematic evaluation across 8 domains – based on recognized standards and regulatory requirements.
Quality, provenance, representativeness, bias analysis
Architecture, training design, reproducibility
Test strategy, subgroup analysis, metrics
Generalization, failure modes, FMEA, stress tests
Interpretability, Grad-CAM, SHAP, clinical plausibility
Versioning, change management, drift detection
Technical file, model cards, traceability
MDR mapping, EU AI Act, risk classification
Referenced Standards & Frameworks
A clearly structured process – transparent, confidential and risk-free in the first step.
No obligation, free of charge. We clarify your needs, the context of your model and whether I'm the right partner for you.
After signing a non-disclosure agreement (NDA), we define scope, objectives and timeline – you receive a transparent fixed-price or time-and-materials proposal.
Structured, independent analysis of your AI/ML model along the assessment framework – with interim alignments to keep everything grounded in your reality.
You receive a clear findings report with prioritized risks and actionable next steps – including a results presentation on request.
Dr.-Ing. Ralf Lutchen
PhD Data Scientist · Independent AI/ML Assessment
Doctoral-level Data Scientist (Dr.-Ing.) with over 15 years of experience in safety-critical technology and industrial software. My path bridges mechatronics, machine learning, IoT architecture and regulated product development – from commissioning real machines to production-grade AI systems.
As a Data Scientist, I build AI solutions at production level – meeting the demands on validation, reproducibility and robustness that an industrial environment imposes. My doctorate (graded 1.0, highest distinction) combined artificial intelligence, software architecture, IoT and cyber security: I developed a cloud-based AI method that reads vehicle networks and controls safety-relevant interventions.
This domain's requirements for functional safety, traceability and validation are closely related to those of medical technology. That is exactly the bridge I bring to RaMed: I transfer proven AI-validation methods from safety-critical industries to the regulatory requirements of medical technology – MDR, IEC 62304, ISO 14971 and the EU AI Act.
My approach follows established frameworks: CRISP-DM for data science workflows, arc42 for architecture documentation of larger systems. Extensive DevOps experience enables me to assess not just the model, but also data architecture, solution architecture and the full MLOps pipeline.
"I see what internal teams typically miss – the bridge between ML development and regulated reality."
What clients typically want to know before working together.
Before any substantive collaboration, we sign a non-disclosure agreement (NDA). Your data, models and documents are used solely for the agreed assessment, never shared with third parties, and deleted or returned after project completion on request.
No. I provide an independent technical assessment and actionable recommendations. This does not replace review by notified bodies, authorities or certifying institutions – but my work prepares you specifically for it.
A Quick Risk Check delivers initial results in around 5–10 business days. A full Technical Assessment depends on scope and complexity and is defined together during scoping.
Pricing depends on scope and depth and is agreed transparently in advance, as a fixed price or based on effort. During the current 2026 launch phase, I work with selected pilot clients at reduced rates.
Typically information on data and data provenance, training and validation strategy, model architecture and existing documentation. In the first call we clarify what is genuinely useful – missing pieces are often part of the findings themselves.
Yes. Collaboration is predominantly remote; documents and alignment happen digitally and securely. The assessment is available in German and English.
In a no-obligation first call, we gain clarity on your critical risks – in good time, before approval does.
Get in Touch